• 1
    Habib G, Hoen B, Tomos P, et al. Guidelines on the prevention, diagnosis and treatment of infective endocarditis (new version 2009). The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J. 2009;30:23692413.
  • 2
    Wang A, Athan E, Pappas PA, et al. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA. 2007;297: 13541361.
  • 3
    Leon MB, Piazza M, Nikolsky E, et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J. 2011;32:205217.
  • 4
    Chrissoheris MP, Ferti A, Spargias K. Early prosthetic valve endocarditis complicating repeated attempts at CoreValve implantation. J Invasive Cardiol. 2011;23:E291E292.
  • 5
    Kodali SK, Williams MR, Smith CR, et al; for the PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aortic valve replacement. N Engl J Med. 2012;366:16861695.
  • 6
    Makkar RR, Fontana GP, Jilaihawi H, et al; for the PARTNER Trial Investigators. Transcatheter aortic valve replacement for inoperable severe aortic stenosis. N Engl J Med. 2012;366:16961704.
  • 7
    Thomas M, Schymik G, Walther T, et al. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2011;124:425433.
  • 8
    Kodali SK, O'Neill WW, Moses JW, et al. Early and late (one year) outcomes following transcatheter aortic valve implantation in patients with severe aortic stenosis (from the United States REVIVAL trial). Am J Cardiol. 2011;107:10581064.
  • 9
    Gurvitch R, Wood DA, Tay EL, et al. Transcatheter aortic valve implantation: durability of clinical and hemodynamic outcomes beyond 3 years in a large patient cohort. Circulation. 2010;122: 13191327.
  • 10
    Buellesfeld L, Gerckens U, Schuler G, et al. 2-year follow-up of patients undergoing transcatheter aortic valve implantation using a self-expanding valve prosthesis. J Am Coll Cardiol. 2011;57: 16501657.
  • 11
    Ye J, Cheung A, Lichtenstein SV, et al. Transapical transcatheter aortic valve implantation: follow-up to 3 years. J Thorac Cardiovasc Surg. 2010;139:11071113.
  • 12
    Virmani R. Analysis of human necropsy transcatheter heart valve specimens: valve design differences, durability predictions and comparison with surgical valves. Presented at: Transcatheter Cardiovascular Therapeutics (TCT) Conference; November 7, 2011; San Francisco, California.
  • 13
    Sinning JM, Scheer AC, Adenauer V, et al. Systemic inflammatory response syndrome predicts increased mortality in patients after transcatheter aortic valve implantation. Eur Heart J. 2012;33: 14591468.
  • 14
    Santos M, Thiene G, Sievers HH, et al. Candida endocarditis complicating transapical aortic valve implantation. Eur Heart J. 2011; 32:2265.
  • 15
    Gotzmann M, Mügge A. Fatal prosthetic valve endocarditis of the CoreValve revalving system. Clin Res Cardiol. 2011;100:715717.
  • 16
    Vidal-Pérez R, Bordes-Galan S, del Valle Pedrosa del Moral M, et al. The new endocarditis are here. Presented at: European Society of Cardiology Congress, September 2, 2010; Stockholm, Sweden.
  • 17
    Comoglio C, Boffini M, El Qarra S, et al. Aortic valve replacement and mitral valve repair as treatment of complications after percutaneous CoreValve implantation. J Thorac Cardiovasc Surg. 2009;138:10251027.
  • 18
    Wong DR, Boone RH, Thompson CR, et al. Mitral valve injury late after transcatheter aortic valve implantation. J Thorac Cardiovasc Surg. 2009;137:15471549.
  • 19
    Loh PH, Ihleman N, Bundgaard H, et al. Infective endocarditis following transcatheter aortic valve implantation: diagnostic and management challenges. Presented at: PCR London Valves Congress; October 17, 2011; London, England.
  • 20
    Head SJ, Dewey TM, Mack MJ. Fungal endocarditis after transfemoral aortic valve implantation. Catheter Cardiovasc Interv. 2001;78:10171019.
  • 21
    Rafiq I, Parthasarathy H, Tremlett C, et al. Infective endocarditis caused by Moraxella nonliquefaciens in a percutaneous aortic valve replacement. Cardiovasc Revasc Med. 2011;12:184186.
  • 22
    Carnero-Alcázar M, Maroto Castellanos LC, Carnicer JC, et al. Transapical aortic valve prosthetic endocarditis. Interact Cardiovasc Thorac Surg. 2010;11:252253.
  • 23
    Piazza N, Marra S, Webb J, et al. Two cases of aneurysm of the anterior mitral valve leaflet associated with transcatheter aortic valve endocarditis: a mere coincidence? J Thorac Cardiovasc Surg. 2010;140:e36e38.